Research article · 2015
Conference abstract
Hot Melt Extrusion: Processing Solid Solutions
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
With the advent of high throughput screening and combinatorial chemistry, there are now many drug compounds that exhibit poor bioavailability due to limited intestinal fluid solubility. Improving the solubility of these compounds is one of the major challenges facing the pharmaceutical industry. Numerous methods have been employed to increase the solubility of these drugs, one of which is the use of solid drug dispersions. Typically, solid dispersions are prepared using organic solvents, but this is problematic because of environmental and toxicological issues. Additionally, process scale-up is often difficult. Over the last decade hot-melt extrusion (HME) has been actively adapted for pharmaceutical purposes resulting in a renewed interest in use of solid dispersions as a way to improve the solubility of poorly water-soluble drugs. HME is a continuous process offering several manufacturing advantages. Successful commercial applications of solid dispersions produced by hot-melt extrusion, such as Kaletra�, show the potential of this technology in bringing new drugs to market. This presentation provides a background on solid dispersions and HME, and subsequently evaluates the research being conducted in this area for the purpose of enhancing the solubility of poorly water-soluble drugs. Much of the research thus far has focused on assessing the performance of various hydrophilic polymers as carrier platforms. However, more recently the effects of process/formulation factors have been investigated. It is anticipated that over the next five years the full potential of HME will be realised with more drugs being successfully formulated as solid dispersions and subsequently marketed.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 3 May 2019
Design and evaluation of tolvaptan solid dispersions using hot-melt extrusion and spray drying technique Ã?¢Ã?â?¬Ã?â?? A comparative study
Conference abstract · 17 Sep 2018
Application of hot melt extrusion technology in development of solid dispersion systems for poorly watersoluble drugs
Conference abstract · 2020
Pharma-2012 : Suitability of plasticised polymers for hot melt extrusion process ethyl alcohol as desolvating agent - Amol M. Sabale - Tatyasaheb Kore College of Pharmacy
Conference abstract · 7 May 2018
Influence of hot melt extrusion processing parameters on the properties of a pharmaceutical formulation
More from this journal
The newest in Pharmaceutica Analytica Acta.
Article · 16 Sep 2026
The Fc Domains in the Monoclonal Antibody and Fusion Protein Significantly Boost the Biocomposite Suspension's Power to Combat Harmful Microorganisms, Enhance Drug Delivery, and Improve Protein Stability
Article · 26 Jun 2026
Green Pathways in Drug Quality Assessment: The Growing Role of Sustainable Pharmaceutical Analytics
Article · 26 Jun 2026
Advanced Single-Cell Signal Analysis: The Role of Ghost Cytometry in Cell Therapy Characterization
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Gavin P Andrews”

